Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 467.40
+1.70 (0.37%)
Sep 19, 2025, 4:59 PM CET
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 32.91 billion as of September 19, 2025. Its market cap has decreased by -47.35% in one year.
Market Cap
32.91B
Enterprise Value
16.73B
Revenue
9.11B
Ranking
n/a
PE Ratio
4.99
Stock Price
467.40
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 1.41B to 32.91B, an increase of 2,240.87%. That is a compound annual growth rate of 23.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 32.91B | -34.90% |
| Dec 30, 2024 | 50.55B | 132.03% |
| Dec 29, 2023 | 21.79B | 110.16% |
| Dec 30, 2022 | 10.37B | 65.31% |
| Dec 30, 2021 | 6.27B | -28.46% |
| Dec 30, 2020 | 8.77B | 3.46% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,726.72B |
| Coloplast | 133.39B |
| Genmab | 111.26B |
| Demant | 50.70B |
| ALK-Abelló | 46.85B |
| H. Lundbeck | 42.83B |
| Ambu A/S | 26.23B |
| Bavarian Nordic | 18.07B |